title: Lomustine use in combination with etoposide, cytarabine and melphalan in a brief conditioning regimen for auto-HSCT in patients with lymphoma: the optimal dose.
authors.affiliation: Universidade Federal de Juiz de Fora, Division of Hematology and Bone Marrow Transplantation, Minas Gerais, Brazil.
authors.forename: K B
authors.initials: KB
authors.lastname: dos Santos
authors.affiliation: Medical University of South Carolina, Division of Hematology/Oncology, Charleston, SC, USA.
authors.forename: L J
authors.initials: LJ
authors.lastname: Costa
authors.affiliation: Universidade Federal de Juiz de Fora, Division of Clinical Medical, Minas Gerais, Brazil.
authors.forename: A
authors.initials: A
authors.lastname: Atalla
authors.affiliation: Universidade Federal de São Paulo, Division of Hematology, São Paulo, Brazil.
authors.forename: J
authors.initials: J
authors.lastname: Pereira
authors.affiliation: Universidade Federal de Juiz de Fora, Division of Clinical Medical, Minas Gerais, Brazil.
authors.forename: A E
authors.initials: AE
authors.lastname: Hallack-Neto
mesh_terms: D000293:Adolescent; D000328:Adult; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage*; D015331:Cohort Studies; D003561:Cytarabine / Q000008:administration & dosage; D005047:Etoposide / Q000008:administration & dosage; D005260:Female; D018380:Hematopoietic Stem Cell Transplantation / Q000379:methods*; D006801:Humans; D008130:Lomustine / Q000008:administration & dosage; D008223:Lymphoma / Q000188:drug therapy / Q000628:therapy*; D008297:Male; D008558:Melphalan / Q000008:administration & dosage; D008875:Middle Aged; D019172:Transplantation Conditioning / Q000379:methods*; D055815:Young Adult
chemical_list: D003561:Cytarabine; D005047:Etoposide; D008130:Lomustine; D008558:Melphalan